Cite
HARVARD Citation
Xu, J. et al. (2022). 240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C. Journal of viral hepatitis. 29 (10), pp. 862-867. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xu, J. et al. (2022). 240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C. Journal of viral hepatitis. 29 (10), pp. 862-867. [Online].